Isoniazid

异烟肼

Report date: 2023/02/28 20:00:44
NME

Base Information

Drug NameIsoniazid
Drug Alias Name异烟胼Isonicotinic Acid Hydrazide异菸肼isoniazidumisoniazide +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaLupus Erythematosus, Systemic +[12] 
Global Approved IndicationsTuberculosis, PulmonaryTuberculosis
Approved Indications in ChinaTuberculosis, Pulmonary
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryBulgariaUnited StatesPoland +[13] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Health Clinical Center (Cc)Alfresa PharmaStanford University +[5] 
Inactive CompaniesBridge Bioresearch LtdEpic Pharma LlcMakerere University +[7] 
Active IndicationsLupus Erythematosus, SystemicTuberculosis, PulmonaryTuberculosis
Inactive IndicationsUncomplicated skin and skin structure infectionsCommunity Acquired PneumoniaDiabetic Foot +[9] 

Other Information

ATC CodeJ04AC01
Related LinksWikipediaDrugBankKEGG